mTOR has been considered a master regulator in metabolic adaptation, and mTOR hyperactivity is characteristic for the majority of cancers. Over the last decades, there have been several attempts to characterize the main drivers of metabolic rewiring and their impact on cancer progression. Here, MTOR is linked to cancer.